Abstract
This study evaluated the impact on quality of life (QoL) of an algorithm guiding the responses of continuous subcutaneous insulin infusion (CSII) treated type 1 diabetes (T1D) patients using real-time (RT) continuous glucose monitoring (CGM).
Original language | English |
---|---|
Pages (from-to) | 105 - 109 |
Number of pages | 5 |
Journal | Diabetes Technology and Therapeutics |
Volume | 13 |
Issue number | 2 |
DOIs | |
Publication status | Published - 2011 |